NovoCure Investors: August 18, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser

SAN FRANCISCO, CA – (June 29, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in NovoCure Limited (“NovoCure” or the “Company”) who suffered losses from purchasing or otherwise acquiring NovoCure securities (NASDAQ: NVCR) between January 5, 2023 and June 5, 2023 to contact us immediately regarding pending securities fraud